Michael A. O’Donnell

12.1k total citations · 1 hit paper
242 papers, 8.2k citations indexed

About

Michael A. O’Donnell is a scholar working on Surgery, Immunology and Urology. According to data from OpenAlex, Michael A. O’Donnell has authored 242 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Surgery, 52 papers in Immunology and 49 papers in Urology. Recurrent topics in Michael A. O’Donnell's work include Bladder and Urothelial Cancer Treatments (168 papers), Urinary and Genital Oncology Studies (115 papers) and Urological Disorders and Treatments (30 papers). Michael A. O’Donnell is often cited by papers focused on Bladder and Urothelial Cancer Treatments (168 papers), Urinary and Genital Oncology Studies (115 papers) and Urological Disorders and Treatments (30 papers). Michael A. O’Donnell collaborates with scholars based in United States, Canada and Netherlands. Michael A. O’Donnell's co-authors include Yi Luo, Badrinath R. Konety, Fadi N. Joudi, William C. DeWolf, Xiaohong Chen, Kenneth G. Nepple, Andrew M. Jackson, A.B. Alexandroff, Keith James and Ryan L. Steinberg and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Michael A. O’Donnell

228 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer

2023 60 citations Ian M. McElree, Ryan L. Steinberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. O’Donnell United States	52	4.9k	2.2k	1.5k	1.5k	1.4k	242	8.2k
H. P. Redmond Ireland	55	2.5k 0.5×	1.7k 0.8×	2.3k 1.5×	273 0.2×	2.0k 1.5×	276	9.9k
Andreas Böhle Germany	43	8.7k 1.8×	1.4k 0.6×	1.9k 1.2×	2.6k 1.8×	1.9k 1.4×	150	10.6k
Masato Fujisawa Japan	47	3.0k 0.6×	384 0.2×	2.6k 1.7×	1.4k 0.9×	1.6k 1.2×	686	10.7k
Soichi Arakawa Japan	38	1.3k 0.3×	339 0.2×	1.3k 0.9×	575 0.4×	791 0.6×	298	5.0k
Taiji Tsukamoto Japan	43	2.1k 0.4×	444 0.2×	1.7k 1.1×	2.7k 1.8×	942 0.7×	365	7.9k
Larry W. Moreland United States	59	1.4k 0.3×	4.7k 2.1×	1.8k 1.2×	124 0.1×	1.5k 1.1×	291	18.9k
G. D. CHISHOLM United Kingdom	37	1.9k 0.4×	720 0.3×	625 0.4×	983 0.7×	478 0.4×	213	5.0k
David Chia United States	45	1.7k 0.3×	1.2k 0.6×	3.7k 2.4×	130 0.1×	1.6k 1.2×	146	9.0k
A. Brian West United States	34	2.7k 0.6×	585 0.3×	1.2k 0.8×	114 0.1×	813 0.6×	83	6.0k
Manikkam Suthanthiran United States	56	3.2k 0.6×	2.9k 1.3×	3.1k 2.0×	87 0.1×	2.5k 1.9×	227	12.6k

Countries citing papers authored by Michael A. O’Donnell

Since Specialization

Citations

This map shows the geographic impact of Michael A. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. O’Donnell more than expected).

Fields of papers citing papers by Michael A. O’Donnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. O’Donnell. The network helps show where Michael A. O’Donnell may publish in the future.

Co-authorship network of co-authors of Michael A. O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. O’Donnell. A scholar is included among the top collaborators of Michael A. O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. O’Donnell. Michael A. O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McElree, Ian M., Ryan L. Steinberg, Helen Y. Hougen, et al.. (2025). Long‐term outcomes of a cascading salvage strategy for high‐risk non‐muscle‐invasive bladder cancer. British Journal of Urology. 137(2). 339–347.

Packiam, Vignesh T., Ian M. McElree, Saum Ghodoussipour, et al.. (2025). Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder Cancer. European Urology Oncology. 8(6). 1461–1465.

McElree, Ian M., Sarah L. Mott, Helen Y. Hougen, et al.. (2025). Bladder-sparing management for high grade noninvasive urothelial carcinoma of the prostate. Urologic Oncology Seminars and Original Investigations. 43(9). 521.e1–521.e8.

McElree, Ian M., et al.. (2024). Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 42(9). 289.e13–289.e21. 4 indexed citations

McElree, Ian M., et al.. (2024). ONCOLOGIC OUTCOMES OF BLADDER-SPARING MANAGEMENT FOR HIGH-GRADE NON-INVASIVE UROTHELIAL CARCINOMA OF THE PROSTATIC URETHRA. Urologic Oncology Seminars and Original Investigations. 42. S45–S46. 2 indexed citations

Luo, Yi, et al.. (2024). Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer. Frontiers in Bioscience-Landmark. 29(8). 295–295. 4 indexed citations

Robinson, Robert A., et al.. (2024). Leiomyosarcoma of the prostate: a novel approach to treatment—case report and review of the literature. Journal of Surgical Case Reports. 2024(3). rjae138–rjae138. 1 indexed citations

Kulkarni, Girish S., Kyle A. Richards, Peter C. Black, et al.. (2023). MP63-01 AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS). The Journal of Urology. 209(Supplement 4). 3 indexed citations

Akiyama, Yoshiyuki, Jianrong Yao, Karl J. Kreder, et al.. (2020). Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis. American Journal of Physiology-Renal Physiology. 320(2). F174–F182. 18 indexed citations

10.

O’Donnell, Michael A., et al.. (2018). Parallel strategies for the synthesis of annulated pyrido[3,4-b]indoles via Rh(I)- and Pd(0)-catalyzed cyclotrimerization. Tetrahedron Letters. 59(49). 4311–4314. 7 indexed citations

11.

Steinberg, Ryan L., et al.. (2017). Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non–muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 35(12). 670.e7–670.e14. 17 indexed citations

12.

Wang, Xu, Susan K. Lutgendorf, Catherine S. Bradley, et al.. (2016). Transgenic Mice Expressing MCP-1 by the Urothelium Demonstrate Bladder Hypersensitivity, Pelvic Pain and Voiding Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study. PLoS ONE. 11(9). e0163829–e0163829. 15 indexed citations

13.

Steinberg, Ryan L., Lewis J. Thomas, Sarah L. Mott, & Michael A. O’Donnell. (2016). Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease. Bladder Cancer. 2(2). 215–224. 25 indexed citations

14.

Lightfoot, Andrew J., Benjamin N. Breyer, Henry Rosevear, et al.. (2013). Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(1). 35.e15–35.e19. 85 indexed citations

15.

Streeper, Necole M., et al.. (2008). The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. British Journal of Urology. 103(4). 475–479. 65 indexed citations

16.

Ryan, Anthony A., Teresa M. Wozniak, Elena Shklovskaya, et al.. (2007). Improved Protection against Disseminated Tuberculosis by Mycobacterium bovis Bacillus Calmette-Guerin Secreting Murine GM-CSF Is Associated with Expansion and Activation of APCs. The Journal of Immunology. 179(12). 8418–8424. 33 indexed citations

17.

Saban, Marcia R., Helen L. Hellmich, Cindy Simpson, et al.. (2007). Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. BMC Cancer. 7(1). 204–204. 20 indexed citations

18.

O’Donnell, Michael A., et al.. (2004). INTERIM RESULTS FROM A NATIONAL MULTICENTER PHASE II TRIAL OF COMBINATION BACILLUS CALMETTE-GUERIN PLUS INTERFERON ALFA-2B FOR SUPERFICIAL BLADDER CANCER. The Journal of Urology. 172(3). 888–893. 82 indexed citations

19.

Joudi, Fadi N., Bruce A. Smith, Michael A. O’Donnell, & Badrinath R. Konety. (2003). Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis. Urology. 62(6). 1083–1088. 34 indexed citations

20.

Tobian, Louis, Michael A. O’Donnell, & M Ganguli. (1978). Relationship of prostaglandins and sodium in renal papilla in Kyoto hypertensive rats and during high sodium diets.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 91. 204–11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact